Zeaxanthin From Leafy Greens May Supercharge Cancer Immunotherapy

Researchers at the University of Chicago have identified zeaxanthin, a carotenoid commonly found in leafy greens and used for eye health, as a powerful immune system enhancer that could revolutionize cancer treatment. Published in Cell Reports Medicine, this groundbreaking study reveals how a simple dietary nutrient might significantly improve cancer immunotherapy outcomes.

The research team discovered that zeaxanthin directly strengthens CD8+ T cells, the immune system's primary cancer-fighting cells. By stabilizing T-cell receptor formation, zeaxanthin enhances these cells' ability to detect and destroy cancer cells while boosting cytokine production and internal signaling pathways.

In animal studies, dietary zeaxanthin supplementation slowed tumor growth substantially. When combined with immune checkpoint inhibitors—a leading immunotherapy approach—the effects were even more pronounced, producing superior anti-tumor responses compared to immunotherapy alone. Laboratory experiments using engineered human T cells showed enhanced destruction of melanoma, multiple myeloma, and glioblastoma cancer cells.

This discovery is particularly exciting because zeaxanthin is already widely available as an inexpensive, well-tolerated supplement. Found naturally in orange peppers, spinach, and kale, it represents an accessible complementary approach to existing cancer treatments. The research builds on previous work from the same lab identifying other immune-enhancing nutrients, suggesting diet plays a crucial role in cancer immunity.

While human trials are needed to confirm these promising results, the findings offer hope for improving cancer treatment outcomes through simple nutritional interventions that could work alongside conventional therapies.